Published in Immunol Res on January 01, 2009
Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol (2010) 3.27
Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J Exp Med (2012) 2.74
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet (2010) 2.45
Re(de)fining the dendritic cell lineage. Nat Immunol (2012) 2.17
Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization. Nat Immunol (2012) 1.81
Interferon regulatory factors in human lupus pathogenesis. Transl Res (2011) 1.81
Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria. PLoS Pathog (2013) 1.59
Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet (2011) 1.59
Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J Exp Med (2014) 1.44
Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. J Exp Med (2013) 1.26
Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat Commun (2011) 1.23
IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools. J Immunol (2010) 1.22
Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus. Proc Natl Acad Sci U S A (2013) 1.10
Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis. PLoS Genet (2011) 1.02
A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma. Blood (2013) 1.00
IFN regulatory factor 8 is a key constitutive determinant of the morphological and molecular properties of microglia in the CNS. PLoS One (2012) 1.00
The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation. J Exp Med (2014) 1.00
The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells. Nat Genet (2012) 0.97
Interferon regulatory factor 8/interferon consensus sequence binding protein is a critical transcription factor for the physiological phenotype of microglia. J Neuroinflammation (2012) 0.96
The Roles of the Methyl-CpG Binding Proteins in Cancer. Genes Cancer (2011) 0.94
Interferon-regulatory factors determine macrophage phenotype polarization. Mediators Inflamm (2013) 0.93
The Interferon-Signature of Sjögren's Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific Diseases. Front Immunol (2013) 0.90
Association analyses confirm five susceptibility loci for systemic lupus erythematosus in the Han Chinese population. Arthritis Res Ther (2015) 0.89
IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice. J Autoimmun (2014) 0.88
Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma. Immunity (2014) 0.86
Interleukin 27 induces the expression of complement factor H (CFH) in the retina. PLoS One (2012) 0.85
Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease. Mol Neurodegener (2014) 0.85
Innate defects of the IL-12/IFN-γ axis in susceptibility to infections by mycobacteria and salmonella. J Interferon Cytokine Res (2013) 0.81
Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding. J Hematol Oncol (2014) 0.81
ZFP36L1 negatively regulates erythroid differentiation of CD34+ hematopoietic stem cells by interfering with the Stat5b pathway. Mol Biol Cell (2010) 0.81
Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion. Int Immunopharmacol (2011) 0.80
Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes. Cancer Epidemiol Biomarkers Prev (2013) 0.80
Interferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCOR. J Biol Chem (2014) 0.79
Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation. Front Physiol (2014) 0.79
The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases. Br J Pharmacol (2015) 0.78
Cutting Edge: Expression of IRF8 in Gastric Epithelial Cells Confers Protective Innate Immunity against Helicobacter pylori Infection. J Immunol (2016) 0.77
Interferon regulatory factor 8-deficiency determines massive neutrophil recruitment but T cell defect in fast growing granulomas during tuberculosis. PLoS One (2013) 0.77
Loss of IRF8 Inhibits the Growth of Diffuse Large B-cell Lymphoma. J Cancer (2015) 0.77
Genetics of systemic sclerosis. Semin Immunopathol (2015) 0.77
Mysm1 is required for interferon regulatory factor expression in maintaining HSC quiescence and thymocyte development. Cell Death Dis (2016) 0.76
Hematopoiesis in the equine fetal liver suggests immune preparedness. Immunogenetics (2014) 0.76
Predominant Role of Plasmacytoid Dendritic Cells in Stimulating Systemic Autoimmunity. Front Immunol (2015) 0.76
miRNA-451a Targets IFN Regulatory Factor 8 for the Progression of Systemic Lupus Erythematosus. Inflammation (2017) 0.76
Th17 cell differentiation proceeds independently of IRF8. Immunol Cell Biol (2016) 0.75
The prolyl isomerase Pin1 modulates development of CD8+ cDC in mice. PLoS One (2012) 0.75
Comprehensive Transcriptome Meta-analysis to Characterize Host Immune Responses in Helminth Infections. PLoS Negl Trop Dis (2016) 0.75
The Third Intron of the Interferon Regulatory Factor-8 Is an Initiator of Repressed Chromatin Restricting Its Expression in Non-Immune Cells. PLoS One (2016) 0.75
Gene expression comparison of resistant and susceptible Atlantic salmon fry challenged with Infectious Pancreatic Necrosis virus reveals a marked contrast in immune response. BMC Genomics (2016) 0.75
IFN regulatory factors 4 and 8 expression in the NOD mouse. Clin Dev Immunol (2011) 0.75
Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice. Sci Rep (2017) 0.75
Inhibition of IRF8 Negatively Regulates Macrophage Function and Impairs Cutaneous Wound Healing. Inflammation (2016) 0.75
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science (1994) 7.60
B cell development pathways. Annu Rev Immunol (2001) 6.94
Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell (1996) 4.74
Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science (2000) 4.53
TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol (2008) 4.21
An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci U S A (1990) 3.53
Transcriptional control of early B cell development. Annu Rev Immunol (2004) 3.22
Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood (2005) 2.64
The protean nature of cells in the B lymphocyte lineage. Immunity (2007) 2.64
IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int Immunol (1994) 2.51
Assembling a gene regulatory network for specification of the B cell fate. Dev Cell (2004) 2.46
Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev (1996) 2.43
Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity (1999) 2.35
ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity (2000) 2.34
PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med (2005) 2.34
Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood (2005) 2.32
Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nat Immunol (2008) 2.19
IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev (2003) 2.12
Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J Exp Med (2005) 2.00
Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc Natl Acad Sci U S A (1994) 1.98
Potential autoregulation of transcription factor PU.1 by an upstream regulatory element. Mol Cell Biol (2005) 1.96
PU.1 expression is modulated by the balance of functional sense and antisense RNAs regulated by a shared cis-regulatory element. Genes Dev (2008) 1.90
Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5. Mol Cell Biol (2006) 1.81
Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J Immunol (2007) 1.80
A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice. J Exp Med (2005) 1.74
Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J Exp Med (1997) 1.73
IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development. J Immunol (2006) 1.72
Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP. J Biol Chem (2003) 1.56
IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood (2008) 1.53
Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood (1999) 1.49
Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. Blood (2005) 1.44
The role of the interferon regulatory factor (IRF) family in dendritic cell development and function. Cytokine Growth Factor Rev (2007) 1.38
Regulation of the PU.1 gene by distal elements. Blood (2001) 1.28
Identification of Pax5 target genes in early B cell differentiation. J Immunol (2008) 1.28
PU.1, a shared transcriptional regulator of lymphoid and myeloid cell fates. Cold Spring Harb Symp Quant Biol (1999) 1.23
Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains. Mol Cell Biol (1998) 1.19
Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors. J Biol Chem (1995) 1.15
Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker. Am J Surg Pathol (2008) 1.12
Ubiquitin-dependent degradation of interferon regulatory factor-8 mediated by Cbl down-regulates interleukin-12 expression. J Biol Chem (2005) 1.11
Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? Trends Immunol (2007) 1.04
Gamma interferon triggers interaction between ICSBP (IRF-8) and TEL, recruiting the histone deacetylase HDAC3 to the interferon-responsive element. Mol Cell Biol (2002) 1.03
Decreased IRF8 expression found in aging hematopoietic progenitor/stem cells. Leukemia (2008) 1.00
Nramp1-mediated innate resistance to intraphagosomal pathogens is regulated by IRF-8, PU.1, and Miz-1. J Biol Chem (2003) 0.98
Knockdown of Pu.1 by small interfering RNA in CD34+ embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells. Proc Natl Acad Sci U S A (2005) 0.94
A critical role for IL-21 in regulating immunoglobulin production. Science (2002) 7.09
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood (2002) 4.88
Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol (2004) 4.43
TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol (2008) 4.21
New genes involved in cancer identified by retroviral tagging. Nat Genet (2002) 4.14
ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J Exp Med (2002) 2.92
AID is required for germinal center-derived lymphomagenesis. Nat Genet (2007) 2.79
The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Semin Cancer Biol (2002) 2.66
BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc Natl Acad Sci U S A (2002) 2.62
PNPASE regulates RNA import into mitochondria. Cell (2010) 2.54
Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity. Cancer Res (2002) 2.52
A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc Natl Acad Sci U S A (2009) 2.46
Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J Exp Med (2005) 2.00
Immunoglobulin class switch recombination is impaired in Atm-deficient mice. J Exp Med (2004) 1.87
Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. Cancer Res (2005) 1.83
Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J Immunol (2007) 1.80
The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse. Blood (2007) 1.73
Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts. J Immunol (2009) 1.73
Axon growth and guidance genes identify T-dependent germinal centre B cells. Immunol Cell Biol (2007) 1.60
IL-6 transgenic mouse model for extraosseous plasmacytoma. Proc Natl Acad Sci U S A (2002) 1.55
IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood (2008) 1.53
High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. Cancer Res (2004) 1.38
Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma. J Exp Med (2003) 1.29
Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc Natl Acad Sci U S A (2005) 1.28
Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proc Natl Acad Sci U S A (2002) 1.26
CTCF functions as a critical regulator of cell-cycle arrest and death after ligation of the B cell receptor on immature B cells. Proc Natl Acad Sci U S A (2003) 1.23
Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat Commun (2011) 1.23
c-MYC activates protein kinase A (PKA) by direct transcriptional activation of the PKA catalytic subunit beta (PKA-Cbeta) gene. Oncogene (2002) 1.22
IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools. J Immunol (2010) 1.22
ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood (2003) 1.21
Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. J Immunol (2008) 1.21
Overexpression of Eg5 causes genomic instability and tumor formation in mice. Cancer Res (2007) 1.20
Endophilins interact with Moloney murine leukemia virus Gag and modulate virion production. J Biol (2003) 1.14
Mouse IgM Fc receptor, FCMR, promotes B cell development and modulates antigen-driven immune responses. J Immunol (2012) 1.13
Growth factor independence-1B expression leads to defects in T cell activation, IL-7 receptor alpha expression, and T cell lineage commitment. J Immunol (2003) 1.12
HLA class I and II genotype of the NCI-60 cell lines. J Transl Med (2005) 1.11
Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases. J Exp Med (2010) 1.10
TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice. Proc Natl Acad Sci U S A (2004) 1.09
A novel isoform of the Ly108 gene ameliorates murine lupus. J Exp Med (2011) 1.07
IL-6 and MYC collaborate in plasma cell tumor formation in mice. Blood (2009) 1.07
The homeobox gene Hex induces T-cell-derived lymphomas when overexpressed in hematopoietic precursor cells. Oncogene (2003) 1.06
T cell–derived inducible nitric oxide synthase switches off Th17 cell differentiation. J Exp Med (2013) 1.03
Deregulated expression of the Myc cellular oncogene drives development of mouse "Burkitt-like" lymphomas from naive B cells. Blood (2004) 1.02
The structural complexity of the human BORIS gene in gametogenesis and cancer. PLoS One (2010) 1.02
The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12. Blood (2011) 0.99
NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas. Cancer Res (2008) 0.98
Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells. Cancer Res (2007) 0.97
Expression of a testis-specific form of Gal3st1 (CST), a gene essential for spermatogenesis, is regulated by the CTCF paralogous gene BORIS. Mol Cell Biol (2010) 0.96
IRF8 governs expression of genes involved in innate and adaptive immunity in human and mouse germinal center B cells. PLoS One (2011) 0.96
Evi3, a zinc-finger protein related to EBFAZ, regulates EBF activity in B-cell leukemia. Oncogene (2005) 0.96
Expression of the cyclin-dependent kinase inhibitor p27 and its deregulation in mouse B cell lymphomas. Leuk Res (2005) 0.96
Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks. J Exp Med (2013) 0.94
Eef1a2 promotes cell growth, inhibits apoptosis and activates JAK/STAT and AKT signaling in mouse plasmacytomas. PLoS One (2010) 0.94
IFN regulatory factor 8 regulates MDM2 in germinal center B cells. J Immunol (2009) 0.94
Differential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartments. Immunol Res (2009) 0.93
Identification and characterization of two related murine genes, Eat2a and Eat2b, encoding single SH2-domain adapters. Immunogenetics (2006) 0.92
Routes to covalent catalysis by reactive selection for nascent protein nucleophiles. J Am Chem Soc (2007) 0.90
Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas. Proc Natl Acad Sci U S A (2013) 0.90
ICSBP/IRF-8 differentially regulates antigen uptake during dendritic-cell development and affects antigen presentation to CD4+ T cells. Blood (2006) 0.88
A mutant collagen XIII alters intestinal expression of immune response genes and predisposes transgenic mice to develop B-cell lymphomas. Cancer Res (2008) 0.88
Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation. Proc Natl Acad Sci U S A (2012) 0.88
Evidence for selective transformation of autoreactive immature plasma cells in mice deficient in Fasl. J Exp Med (2004) 0.88
Identification of genes differentially regulated by the P210 BCR/ABL1 fusion oncogene using cDNA microarrays. Exp Hematol (2004) 0.88
MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis. J Immunol (2011) 0.87
PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cells. J Pathol (2010) 0.87
CD19 signaling pathways play a major role for murine AIDS induction and progression. J Immunol (2002) 0.87
Expression of plasma cell alloantigen 1 defines layered development of B-1a B-cell subsets with distinct innate-like functions. Proc Natl Acad Sci U S A (2012) 0.87
Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale. Immunol Lett (2005) 0.86
Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation. Blood (2006) 0.86
Induction of a protein-targeted catalytic response in autoimmune prone mice: antibody-mediated cleavage of HIV-1 glycoprotein GP120. Biochemistry (2006) 0.85
Transitional B cells lose their ability to receptor edit but retain their potential for positive and negative selection. J Immunol (2007) 0.84
Characterization of a novel murine retrovirus mixture that facilitates hematopoiesis. J Virol (2002) 0.83
Alloimmunization against RBC or PLT antigens is independent of TRIM21 expression in a murine model. Mol Immunol (2011) 0.83
IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB.Yaa mice. J Immunol (2013) 0.83
Identification of murine B cell lines that undergo somatic hypermutation focused to A:T and G:C residues. Eur J Immunol (2008) 0.83
A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling. Blood (2007) 0.83
Transcription factor BORIS (Brother of the Regulator of Imprinted Sites) directly induces expression of a cancer-testis antigen, TSP50, through regulated binding of BORIS to the promoter. J Biol Chem (2011) 0.82
Differentiation of rodent immune and hematopoietic system reactive lesions from neoplasias. Toxicol Pathol (2012) 0.82
Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms. Int J Mol Sci (2012) 0.81
Msh6 protects mature B cells from lymphoma by preserving genomic stability. Am J Pathol (2010) 0.80
Histologic and molecular characterizations of megakaryocytic leukemia in mice. Leuk Res (2005) 0.80
CpG DNA induced IL-12 p40 gene activation is independent of STAT1 activation or production of interferon consensus sequence binding protein. J Biomed Sci (2002) 0.80
Anaplastic plasmacytomas: relationships to normal memory B cells and plasma cell neoplasms of immunodeficient and autoimmune mice. J Pathol (2010) 0.79
Genomic instability in mouse Burkitt lymphoma is dominated by illegitimate genetic recombinations, not point mutations. Oncogene (2002) 0.79
Characterization of monoclonal antibodies to the plasma cell alloantigen ENPP1. Hybridoma (Larchmt) (2011) 0.79
An ENU-induced mutation in the lymphotoxin alpha gene impairs organogenesis of lymphoid tissues in C57BL/6 mice. Biochem Biophys Res Commun (2008) 0.79
Oncogenic Myc translocations are independent of chromosomal location and orientation of the immunoglobulin heavy chain locus. Proc Natl Acad Sci U S A (2012) 0.79
Functional deficiency in IL-7 caused by an N-ethyl-N-nitrosourea-induced point mutation. Genetics (2006) 0.79
Identification of candidate B-lymphoma genes by cross-species gene expression profiling. PLoS One (2013) 0.79
Irradiated Blm-deficient mice are a highly tumor prone model for analysis of a broad spectrum of hematologic malignancies. Leuk Res (2009) 0.79
Exon 1 disruption alters tissue-specific expression of mouse p53 and results in selective development of B cell lymphomas. PLoS One (2012) 0.78
The Bcl6 locus is not mutated in mouse B-cell lineage lymphomas. Leuk Res (2002) 0.78
Comment on "Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappa B-dependent cytokine expression in fibroblasts". J Immunol (2009) 0.77
Mouse models of human cancers (part 3). Comp Med (2004) 0.76
Targeted deletion of the gene encoding the La autoantigen (Sjögren's syndrome antigen B) in B cells or the frontal brain causes extensive tissue loss. Mol Cell Biol (2013) 0.76
Homeostatic defects in B cells deficient in the E3 ubiquitin ligase ARF-BP1 are restored by enhanced expression of MYC. Leuk Res (2013) 0.76
A three-stage framework for gene expression data analysis by L1-norm support vector regression. Int J Bioinform Res Appl (2005) 0.75